Drug Type Therapeutic radiopharmaceuticals |
Synonyms- |
Target |
Mechanism FAP modulators(Fibroblast activation protein alpha modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Adenomatous Polyposis Coli | Phase 2 | - | 30 Jun 2025 | |
Esophageal Carcinoma | Phase 2 | - | 30 Jun 2025 | |
Ovarian Cancer | Phase 2 | - | 30 Jun 2025 | |
Pancreatic Ductal Adenocarcinoma | Phase 2 | - | 30 Jun 2025 | |
Stomach Cancer | Phase 2 | - | 30 Jun 2025 | |
Adenocarcinoma of Lung | Preclinical | US | 21 May 2024 |